Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer - Abstract

Intravesical therapy with bacillus Calmette-Guérin has proven effects for reducing recurrence, progression, and death from non-muscle-invasive bladder cancer.

These advantages are seen mainly when appropriate maintenance therapy is used for 1-3 years, in the context of appropriate patient selection, tumor management, and symptom support for potential side effects.

Written by:
Kamat AM, Porten S   Are you the author?

Reference: Eur Urol. 2014 Feb;65(2):267-9 Epub 2013 Oct 26
doi: 10.1016/j.eururo.2013.10.016


PubMed Abstract
PMID: 24199712

UroToday.com Bladder Cancer Section

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe